{
  "id": 17819810,
  "title": "UniQure gets review date and adcomm; Inovia's stock surges after approval",
  "url": "https://urgent.news/2026/11/02/uniqure-gets-review-date-and-adcomm-inovias-stock-surges-after",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-02T16:10:20.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/uniqure-gets-review-date-and-adcomm-inovias-stock-surges-after-approval/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Plus news about AbbVie, Gilead and Tiziana Life Sciences. FDA gives uniQure a review date and adcomm: The agency will decide whether or not to approve UniQure’s high-profile Huntington’s disease gene therapy by May 1 ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}